AGIMIDIN®

Composition: Each film-coated tablet contains:
Lamivudine. . . . . . . . . . . . . . . . . . . . . . .100 mg
Presentation:
Cardboard box containing 3 blisters of 10 film-coated tablets.
Indications:
Agimidin tablets containing lamivudine is indicated for the treatment of chronic hepatitis B in adults with:
– Compensated liver disease (liver is damaged, but its function remains normal) with evidence of active viral replication, persistently elevated serum alanine aminotransferase (ALT) levels and histological evidence of active liver inflammation and/or fibrosis.
– Decompensated liver disease: (liver is damaged and does not function normally) lamivudine should always be used in combination with a second agent, without cross-resistance to lamivudine, to reduce the risk of resistance and to achieve rapid viral suppression.

LIÊN HỆ MUA HÀNG HOẶC CẦN TƯ VẤN

error: Không được phép!